BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35584860)

  • 1. Therapy-resistant dermatomyositis with extensive 'lumbar belt' calcinosis.
    Linan-Barroso JM; Gonzalez-Estrada A; García-Morillo JS
    BMJ Case Rep; 2022 May; 15(5):. PubMed ID: 35584860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcinosis cutis associated with amyopathic dermatomyositis: response to intravenous immunoglobulin.
    Peñate Y; Guillermo N; Melwani P; Martel R; Hernández-Machín B; Borrego L
    J Am Acad Dermatol; 2009 Jun; 60(6):1076-7. PubMed ID: 19467386
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacological treatment in calcinosis cutis associated with connective-tissue diseases.
    Dima A; Balanescu P; Baicus C
    Rom J Intern Med; 2014; 52(2):55-67. PubMed ID: 25338341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous immunoglobulin for treatment of dermatomyositis-associated dystrophic calcinosis.
    Galimberti F; Li Y; Fernandez AP
    J Am Acad Dermatol; 2015 Jul; 73(1):174-6. PubMed ID: 26089058
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of subcutaneous calcinosis in systemic disorders].
    Bienvenu B
    Rev Med Interne; 2014 Jul; 35(7):444-52. PubMed ID: 24880741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regression of cutis calcinosis with diltiazem in adult dermatomyositis.
    Abdallah-Lotf M; Grasland A; Vinceneux P; Sigal-Grinberg M
    Eur J Dermatol; 2005; 15(2):102-4. PubMed ID: 15757822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous immunoglobulin therapy for dystrophic calcinosis cutis: unreliable in our hands.
    Kalajian AH; Perryman JH; Callen JP
    Arch Dermatol; 2009 Mar; 145(3):334; author reply 335. PubMed ID: 19289776
    [No Abstract]   [Full Text] [Related]  

  • 8. Calcinosis universalis complicating juvenile dermatomyositis: improvement after intravenous immunoglobulin therapy.
    Touimy M; Janani S; Rachidi W; Etaouil N; Mkinsi O
    Joint Bone Spine; 2013 Jan; 80(1):108-9. PubMed ID: 22999904
    [No Abstract]   [Full Text] [Related]  

  • 9. Linear amyopathic dermatomyositis with calcinosis cutis responsive to topical sodium thiosulfate.
    Topham C; Haynes D; Frigerio A; Hull C
    Pediatr Dermatol; 2019 Jul; 36(4):e102-e103. PubMed ID: 31134636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complete and sustained resolution of calcinosis universalis in a juvenile dermatomyositis case with mycophenolate mofetil.
    Çakan M; Karadağ ŞG; Ayaz NA
    Turk J Pediatr; 2019; 61(5):771-775. PubMed ID: 32105011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Refractory calcinosis in a patient with dermatomyositis: response to intravenous immune globulin.
    Shahani L
    BMJ Case Rep; 2012 Aug; 2012():. PubMed ID: 22907859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of calcinosis cutis in systemic sclerosis and dermatomyositis: A review of the literature.
    Traineau H; Aggarwal R; Monfort JB; Senet P; Oddis CV; Chizzolini C; Barbaud A; Francès C; Arnaud L; Chasset F
    J Am Acad Dermatol; 2020 Feb; 82(2):317-325. PubMed ID: 31302187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcinosis cutis in juvenile dermatomyositis responsive to aluminum hydroxide treatment.
    Nakagawa T; Takaiwa T
    J Dermatol; 1993 Sep; 20(9):558-60. PubMed ID: 8227711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regression of calcinosis cutis after inkless tattoo in a patient with dermatomyositis: therapeutic potential of microneedling.
    Motlaghzadeh Y; Tabatabai LS; Longo E; Sellmeyer DE
    Osteoporos Int; 2022 Nov; 33(11):2449-2452. PubMed ID: 35881144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of response to intravenous sodium thiosulfate in three cases of extensive connective tissue disease-associated calcinosis cutis.
    Song P; Fett NM; Lin J; Merola JF; Costner M; Vleugels RA
    Br J Dermatol; 2018 Jun; 178(6):1412-1415. PubMed ID: 28667747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcinosis cutis presenting years before other clinical manifestations of juvenile dermatomyositis: report of two cases.
    Wananukul S; Pongprasit P; Wattanakrai P
    Australas J Dermatol; 1997 Nov; 38(4):202-5. PubMed ID: 9431716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subcutaneous immunoglobulin for the treatment of calcinosis associated with juvenile dermatomyositis.
    Rodríguez-Lozano AL; Mata-Aguilera X; Rivas-Larrauri F; Bustamante-Ogando JC; Gutierrez-Hernandez A; Bojalil-Cabildo A; Scheffler-Mendoza S; Yamazaki-Nakashimada M
    Int J Rheum Dis; 2024 Jun; 27(6):e15239. PubMed ID: 38923294
    [No Abstract]   [Full Text] [Related]  

  • 18. [Dermatomyositis and acute interstitial lung disease associated with MDA-5 antibodies: an atypical case].
    Girard C; Vincent T; Bessis D
    Ann Dermatol Venereol; 2013 Oct; 140(10):628-34. PubMed ID: 24090894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of calcinosis cutis in juvenile dermatomyositis with pamidronate.
    Palaniappan P; Lionel AP; Kumar S
    J Clin Rheumatol; 2014 Dec; 20(8):454-5. PubMed ID: 25417690
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical and ultrasound response to intralesional sodium thiosulfate for the treatment of calcinosis cutis in the setting of systemic sclerosis. A case-based review.
    López-Sundh AE; Quintana-Sancho A; Durán-Vian C; Reguero-DelCura L; Corrales-Martínez AF; Gómez-Fernández C; González-López MA
    Clin Rheumatol; 2021 Jul; 40(7):2985-2989. PubMed ID: 33244722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.